MedPath

Analysis of FLT-PET imaging as a predictor of hematologic toxicity of chemotherapy in patients with lung cancer

Not Applicable
Conditions
Primary lung cancer
Registration Number
JPRN-UMIN000027540
Lead Sponsor
Third department of internal medicine, Universtiy of Fukui
Brief Summary

Severe hematological toxicity (HT) (grade3/4) was observed in 40.0% of patients during the first cycle. The ROC curve analyses revealed that the TVP/BSA of L4 was the most discriminative parameter among PET parameters for the prediction of severe HT. Furthermore, the sensitivity, specificity, and accuracy of the TVP/BSA of L4 cut-off of 68.7 to predict grade 3/4 HT were 80.0%, 86.7%, and 84.0%, respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Pregnant woman 2) Patients with metalic device in their body 3) Patients with claustrophobia 4) Other cases attending physician it is determined unsuitable for registration of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath